Ava L Liberman

@WCMCNeurology. Vascular Neurologist (skeptical of this medium and its message)

[Continuum: Lifelong Learning in Neurology @ContinuumAAN]

The April #Cerebrovascular Disease issue with Guest Editor Hooman Kamel, MD, MS (@hoomankamel), is now available on https://t.co/mTa1fc5IMD! @AANMember @WeillCornell #neurology #stroke #MedEd #Neurotwitter

[Hooman Kamel @hoomankamel]

Hopefully this will be helpful for stroke researchers working with administrative data!
👇
Validation of the ICD-10 Code for the National Institutes of Health Stroke Scale Score https://t.co/6GMZA4qgBS
@CircOutcomes @StrokeAHA_ASA @WCMCNeurology

[Ava L Liberman @ava_liberman]

@wechsler_paul @NealSParikhMD @hoomankamel @WCMCNeurology Congrats, Paul. Very nicely done !

[Marialaura Simonetto @ML_Simonetto]

Thank you to @san_murthy and the @WCMCNeurology for the mentorship and support and to all our research partners at Yale and Hopkins!

[Ava L Liberman @ava_liberman]

@JimSiegler @ShyamSprabhak @hoomankamel Also, check out our conceptually related paper recently published on the prevalence of neurological complaints in patients presenting with severe hypertension https://t.co/v6MTQIlEGr

[Ava L Liberman @ava_liberman]

Check out our collaborative project finding that upstream steps are critical in the acute stroke diagnostic process using engineering methods: https://t.co/5KG3hau5Uh Big thank you to my Chicago-based mentors and friends @UChicago_Neuro @Stroke_doc & @ matthew maas

[Mehdi Bouslama, MD, MSc @BouslamaMd]

Access to thrombectomy remains limited in the US and seems worse during extreme off-hours. ⁦@WCMCNeurology⁩ ⁦@hoomankamel⁩ ⁦@NealSParikhMD⁩ ⁦@SVINJournal⁩ ⁦@svinsociety⁩ ⁦@SNISinfo⁩ ⁦@cvsection⁩ #noLVOleftbehind https://t.co/UmJ7kj2NA4

[JAMA Neurology @JAMANeuro]

Study uses data from the National Hospital Ambulatory Medical Care Survey to analyze adults with a neurological complaint as their reason for an emergency department visit. https://t.co/X711n5y2df

[Ava L Liberman @ava_liberman]

@JimSiegler @ShyamSprabhak @hoomankamel Thanks, Siegler!

[Shadi Yaghi @ShadiYaghi2]

What predicts recurrent venous thrombosis after cerebral venous thrombosis? Check out our study highlighting the role of racial inequity/social determinants of health in recurrence risk. So proud of @ShuLiqi and grateful for the ACTION-CVT team. https://t.co/RqZ1YwbD7A

[Headache Journal @HeadacheJournal]

Short-term #stroke risk after emergency department treat-and-release #headache visit
@ava_liberman @CenaiZhang Richard Lipton, @hoomankamel @NealSParikhMD Babak Navi, @nystrokedoc @JunaidRazzakMD @DNewmanToker Alexander Merkler

https://t.co/USZMBmQvkp

[Neal S Parikh MD @NealSParikhMD]

Hi, I promise, last push:

*Please complete* survey on smoking cessation treatments after stroke/TIA.

Stroke docs, neurohospitalists, neurologists who care for #stroke /TIA:

https://t.co/21d88g5cC8

@hoomankamel @draravindganesh @NeurologyCP @StrokeAHA_ASA

[Stroke AHA/ASA @StrokeAHA_ASA]

#OriginalResearch: Risk of #Stroke After Posterior Reversible Encephalopathy Syndrome #AHAJournals https://t.co/ILqbEBNHrJ @hoomankamel @san_murthy @SetarehOmranMD @sarahbellum37 @nealsparikhmd

[Stroke AHA/ASA @StrokeAHA_ASA]

Just Published in #Stroke: Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study @l_farland #AHAJournals https://t.co/e2gYhwtO9X

[Ava L Liberman @ava_liberman]

@gcfmd @JAMAInternalMed @JAMANetwork @DLBHATTMD Great paper! We similarly found high-risk TIA patients did not receive DAPT despite guideline recommendations. https://t.co/dwFK9wMao5

[Gregg Fonarow MD @gcfmd]

after the release of the class I, level of evidence A recommendation, 53.0% of patients with minor ischemic strokes did not receive DAPT

Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke https://t.co/7GRl91Kyzn via @JAMAInternalMed part of @JAMANetwork

@DLBHATTMD

[Ava L Liberman @ava_liberman]

@gcfmd @JAMAInternalMed @JAMANetwork @DLBHATTMD Great paper! We similarly found high-risk TIA patients did not receive DAPT despite guideline recommendations. https://t.co/dwFK9wMao5

[Santosh Murthy @san_murthy]

Great going by @WCMCNeurology resident @stepoh on this @JAMANeuro editorial. https://t.co/QEMAxJTrdK

[Lauren Schaff, MD @LaurenSchaffMD]

Officially published! Low-dose glucarpidase is effective for MTX clearance, even after multiple administrations. Glucarpidase doesn’t affect CSF MTX concentration and may help CNS #lymphoma patients get home faster. https://t.co/oWqvUWiFxp @BMC_series